The largest database of trusted experimental protocols

Parp2 chemiluminescent assay kit

Manufactured by BPS Biosciences
Sourced in United States

The PARP2 Chemiluminescent Assay Kit is a laboratory equipment product designed to measure the activity of the PARP2 enzyme. The kit utilizes a chemiluminescent detection method to quantify PARP2 activity in a simple and efficient manner.

Automatically generated - may contain errors

3 protocols using parp2 chemiluminescent assay kit

1

PARP Enzyme Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PARP1 and PARP2 IC50 for Rucaparib, Veliparib and the various CRBN-based PARP degraders were measured by using a PARP universal chemiluminescent assay kit (Trevigen, #4676–096-K) and PARP2 Chemiluminescent Assay Kit (BPS Bioscience, #80552), respectively. Briefly, the histone-coated strip wells (PARP1) were hydrated with the assay buffer for 30 min. The blank strip wells (PARP2) were coated with histone proteins overnight at 4℃ and blocked with blocking buffer for 90 min. The various compounds were added and were incubated with the PARP enzyme for 10 min. The reaction cocktail containing biotinylated NAD+ was then added into the system, which was incubated for 1 hour to activate PARP enzyme. After the reaction, the wells were washed twice with 0.1% Triton X-100/PBS and twice with PBS (PARP1) or were washed three times with 0.05% Tween-20/PBS (PARP2). The wells were incubated with Strep-HRP for another hour, and were washed again as described above. Peroxy-Glow reagents were mixed and added into the strip wells, and the biotin signal on coated histone was immediately measured with chemiluminescence on a Synergy microplate reader (Bio-Tek). The well without the PARP enzyme, and the well with the PARP enzyme only was used as the negative (0%) and positive (100%) control, respectively.
+ Open protocol
+ Expand
2

PARP Enzyme Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PARP1 and PARP2 IC50 for Rucaparib, Veliparib and the various CRBN-based PARP degraders were measured by using a PARP universal chemiluminescent assay kit (Trevigen, #4676–096-K) and PARP2 Chemiluminescent Assay Kit (BPS Bioscience, #80552), respectively. Briefly, the histone-coated strip wells (PARP1) were hydrated with the assay buffer for 30 min. The blank strip wells (PARP2) were coated with histone proteins overnight at 4℃ and blocked with blocking buffer for 90 min. The various compounds were added and were incubated with the PARP enzyme for 10 min. The reaction cocktail containing biotinylated NAD+ was then added into the system, which was incubated for 1 hour to activate PARP enzyme. After the reaction, the wells were washed twice with 0.1% Triton X-100/PBS and twice with PBS (PARP1) or were washed three times with 0.05% Tween-20/PBS (PARP2). The wells were incubated with Strep-HRP for another hour, and were washed again as described above. Peroxy-Glow reagents were mixed and added into the strip wells, and the biotin signal on coated histone was immediately measured with chemiluminescence on a Synergy microplate reader (Bio-Tek). The well without the PARP enzyme, and the well with the PARP enzyme only was used as the negative (0%) and positive (100%) control, respectively.
+ Open protocol
+ Expand
3

PARP-1 and PARP-2 Inhibition Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PARP-1 and PARP-2 inhibition assays were performed in outsourcing, by a CRO company, Shanghai Medicilon Inc. (Shanghai, China). The PARP-1 and PARP-2 inhibitory activities of the compounds were measured using PARP-1 Chemiluminescent Assay Kit (BPS Bioscience, catalog 80569, San Diego, CA, USA) and PARP-2 Chemiluminescent Assay Kit (BPS Bioscience, catalog 80552), respectively, according to the manufacturer’s instructions. Briefly, PARP-1 or PARP-2 biotinylated substrate was incubated with compounds or solvent control at varying concentrations and an assay buffer containing the PARP-1 or PARP-2 enzyme. After then, the plate was treated with streptavidin-HRP followed by addition of the HRP substrate and the luminescent signal was measured using a chemiluminescence reader (Perkin Elmer Envision 2104 Multi Label Microplate Reader, Waltham, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!